Cutera, Inc. (CUTR) Position Raised by Bank of New York Mellon Corp

Share on StockTwits

Bank of New York Mellon Corp increased its holdings in Cutera, Inc. (NASDAQ:CUTR) by 3.1% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 159,055 shares of the medical device company’s stock after buying an additional 4,810 shares during the period. Bank of New York Mellon Corp owned 1.15% of Cutera worth $5,178,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of the stock. Raymond James & Associates raised its stake in shares of Cutera by 68.4% during the second quarter. Raymond James & Associates now owns 30,900 shares of the medical device company’s stock valued at $1,245,000 after purchasing an additional 12,555 shares during the period. Bank of America Corp DE raised its stake in shares of Cutera by 431.0% during the second quarter. Bank of America Corp DE now owns 31,351 shares of the medical device company’s stock valued at $1,264,000 after purchasing an additional 25,447 shares during the period. Advisors Asset Management Inc. raised its stake in shares of Cutera by 81.0% during the second quarter. Advisors Asset Management Inc. now owns 52,085 shares of the medical device company’s stock valued at $2,099,000 after purchasing an additional 23,315 shares during the period. Northern Trust Corp raised its stake in shares of Cutera by 2.9% during the second quarter. Northern Trust Corp now owns 222,404 shares of the medical device company’s stock valued at $8,962,000 after purchasing an additional 6,249 shares during the period. Finally, United Services Automobile Association purchased a new stake in shares of Cutera during the second quarter valued at approximately $208,000.

CUTR stock opened at $15.34 on Thursday. Cutera, Inc. has a twelve month low of $12.32 and a twelve month high of $56.05. The company has a market cap of $204.53 million, a PE ratio of 19.92 and a beta of 0.72.

CUTR has been the topic of a number of analyst reports. ValuEngine upgraded shares of Cutera from a “hold” rating to a “buy” rating in a research note on Thursday, November 1st. Zacks Investment Research raised shares of Cutera from a “strong sell” rating to a “hold” rating in a research report on Wednesday, December 5th. BidaskClub downgraded shares of Cutera from a “hold” rating to a “sell” rating in a research report on Tuesday, December 11th. Finally, Maxim Group reissued a “hold” rating on shares of Cutera in a research report on Tuesday, January 8th. Three investment analysts have rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average price target of $39.24.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally published by Week Herald and is owned by of Week Herald. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of US and international copyright laws. The original version of this piece of content can be read at https://weekherald.com/2019/02/14/cutera-inc-cutr-position-raised-by-bank-of-new-york-mellon-corp.html.

Cutera Company Profile

Cutera, Inc, a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating.

Featured Story: Retained Earnings

Want to see what other hedge funds are holding CUTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cutera, Inc. (NASDAQ:CUTR).

Institutional Ownership by Quarter for Cutera (NASDAQ:CUTR)

Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply